Cart
sales@molnova.com
Rolziracetam
CAS No. 18356-28-0
Rolziracetam( CI-911 )
Catalog No. M26809 CAS No. 18356-28-0
Rolziracetam is a nootropic drug of the racetam family. It can improve short-term memory in rats and monkeys.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 92 | In Stock |
|
| 5MG | 84 | In Stock |
|
| 10MG | 130 | In Stock |
|
| 25MG | 221 | In Stock |
|
| 50MG | 319 | In Stock |
|
| 100MG | 456 | In Stock |
|
| 200MG | 634 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRolziracetam
-
NoteResearch use only, not for human use.
-
Brief DescriptionRolziracetam is a nootropic drug of the racetam family. It can improve short-term memory in rats and monkeys.
-
DescriptionRolziracetam is a nootropic drug of the racetam family. It can improve short-term memory in rats and monkeys.
-
In Vitro——
-
In Vivo——
-
SynonymsCI-911
-
PathwayOthers
-
TargetOther Targets
-
RecptorTyrosine 3-monooxygenase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number18356-28-0
-
Formula Weight139.154
-
Molecular FormulaC7H9NO2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (718.65 mM)
-
SMILESO=C1CCC2CCC(=O)N12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Khakimova GR, et al. "Provocation test" as a novel approach to early diagnosis of Parkinson's disease. Dokl Biol Sci. 2015;460:17-9.
molnova catalog
related products
-
Frovocimab
Frovocimab (LY 3015014) is a humanized IgG4 monoclonal antibody to Subtilisin/Kexin Protein Converting Enzyme Type 9 (PCSK9) that binds to the catalytic domain of PCSK9 and lowers low-density lipoprotein cholesterol (LDL-C) in patients with hypercholesterolemia.Frovocimab is used in the study of hypercholesterolemia.
-
DMHCA
DMHCA is a selective LXR agonist with anti-inflammatory activity, which induces ABCA1 expression and upregulates FASN and SREBP-1alpha gene expression.
-
Magnolignan A
Magnolignan A-2-O-beta-D-glucopyranoside has medium cytotoxic activity against HEp-2 and HepG2 cells, with IC(50) of 13.3 microM, and 46.4 microM, respectively.
